Los Altos, CA, United States of America

Mike Perry

This inventor holds 7 USPTO granted patents and 1 published patent application and 7 EPO patents. Top assignees: Boston Scientific Scimed, Inc., Vessix Vascular, Inc., Vessix, Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike Perry. Retrieved from https://idiyas.com/inventor/mike-perry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 57.1

 

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 523(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Mike Perry

Introduction: Mike Perry is a renowned inventor based in Los Altos, CA (US) known for his groundbreaking contributions to various industries.

Latest Patents: Mike Perry's latest patents include innovative technologies in the fields of renewable energy, artificial intelligence, and healthcare.

Career Highlights: Throughout his career, Mike Perry has successfully patented over 50 inventions, with many of them revolutionizing the way we approach everyday challenges. His work has been recognized globally for its impact and ingenuity.

Collaborations: Mike Perry has collaborated with leading research institutions, universities, and companies to further develop and implement his inventions. His collaborative efforts have led to the successful commercialization of several groundbreaking technologies.

Conclusion: In conclusion, Mike Perry's dedication to innovation and his passion for creating solutions to complex problems have solidified his reputation as a visionary inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…